Bill Risks Confusion To Curb FDA's Already-Lax App Oversight

Law360, New York (October 29, 2013, 7:33 PM EDT) -- A bipartisan bid to restrict federal oversight of mobile medical apps could create confusion as it tries to solve a problem many observers say doesn't really exist, given the U.S. Food and Drug Administration's hands-off approach to the software so far.

The bill unveiled last week, sponsored by three Republicans and three Democrats, would allow FDA to continue policing apps that function as medical devices but would bar the agency from supervising less-risky software.

Attorneys concede that lawmakers have a worthy goal of encouraging innovation and...
To view the full article, register now.